Technical Analysis for DXCM - DexCom, Inc.

Grade Last Price % Change Price Change
grade D 118.91 0.74% 0.87
DXCM closed up 0.36 percent on Monday, May 20, 2019, on 51 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Flat
See historical DXCM trend table...

Date Alert Name Type % Chg
Bollinger Band Squeeze Range Contraction 0.37%
Outside Day Range Expansion 0.37%
Bollinger Band Squeeze Range Contraction 0.74%
Fell Below 20 DMA Bearish -0.42%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -0.42%
Bollinger Band Squeeze Range Contraction -0.42%
Multiple of Ten Bearish Other -0.42%
BB Squeeze Started Range Contraction -0.42%
Inside Day Range Contraction -0.42%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -2.12%

Older signals for DXCM ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring systems. The company offers its systems for ambulatory use by people with diabetes; and for use by healthcare providers in the hospital for the treatment of patients with and without diabetes. Its ambulatory product line includes SEVEN PLUS, DexCom G4 system, and DexCom G4 PLATINUM system for adults with diabetes to detect trends and track glucose patterns, to aid in the detection of hypoglycemia and hyperglycemia, and to facilitate acute and long-term therapy adjustments. The company's in-hospital product line comprises GlucoClear, a blood-based in-vivo automated glucose monitoring system for use by healthcare providers in the hospital. It also offers SweetSpot, a software platform that enables patients to aggregate and analyze data from diabetes devices and to share it with their healthcare providers. The company markets its products directly to endocrinologists, physicians, and diabetes educators primarily in the United States. DexCom, Inc. was founded in 1999 and is headquartered in San Diego, California.
Medicine Diabetes Healthcare Providers Endocrine System Diabetes Mellitus Medical Monitoring Endocrinology Software Platform Blood Glucose Monitoring Continuous Glucose Monitor Hyperglycemia Hypoglycemia
Is DXCM a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 156.16
52 Week Low 85.76
Average Volume 1,341,487
200-Day Moving Average 131.6191
50-Day Moving Average 123.7476
20-Day Moving Average 119.827
10-Day Moving Average 118.775
Average True Range 4.5865
ADX 16.76
+DI 16.1424
-DI 20.3734
Chandelier Exit (Long, 3 ATRs ) 111.9905
Chandelier Exit (Short, 3 ATRs ) 121.1995
Upper Bollinger Band 124.2407
Lower Bollinger Band 115.4133
Percent B (%b) 0.35
BandWidth 7.366787
MACD Line -1.0091
MACD Signal Line -1.2778
MACD Histogram 0.2687
Fundamentals Value
Market Cap 10.26 Billion
Num Shares 86.6 Million
EPS -0.76
Price-to-Earnings (P/E) Ratio -155.88
Price-to-Sales 6.08
Price-to-Book 10.87
PEG Ratio -1.59
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 125.02
Resistance 3 (R3) 124.73 122.25 123.93
Resistance 2 (R2) 122.25 120.59 122.40 123.56
Resistance 1 (R1) 120.36 119.56 121.31 120.65 123.20
Pivot Point 117.89 117.89 118.36 118.03 117.89
Support 1 (S1) 116.00 116.22 116.94 116.29 113.74
Support 2 (S2) 113.52 115.19 113.67 113.38
Support 3 (S3) 111.63 113.52 113.01
Support 4 (S4) 111.92